Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,160.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,635.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 1,347
  • Market Cap: £216.65m

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-20 Exercise of option Peter John Harrison 1,350.00p 30,000 £405,000.00
01-Apr-20 Sell Peter John Harrison 3,600.00p 30,000 £1,080,000.00
25-Oct-19 Sell Ian James Nicholson 3,158.67p 2,500 £78,966.75

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
01-Apr-20 Sell Peter John Harrison 3,600.00p 30,000 £1,080,000.00
02-Apr-20 Exercise of option Peter John Harrison 1,350.00p 30,000 £405,000.00
25-Oct-19 Sell Ian James Nicholson 3,158.67p 2,500 £78,966.75

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 518,176 £21,556,122
Ian James Nicholson 15,500 £644,800

Major Shareholders

Notifier** Holding Value*
Castlefield Fund Partners Limited 985,000 £40,976,000
Liontrust Investment Partners LLP 522,411 £21,732,298
Canaccord Genuity Group Inc 512,143 £21,305,149
Miton Group plc 508,135 £21,138,416
Gresham House Asset Management Limited 355,675 £14,796,080
The Diverse Income Trust plc 302,300 £12,575,680
Wasatch Advisors, Inc. 265,000 £11,024,000
Adrian Williams 253,372 £10,540,275

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,160.00p
Change Today 10.00p
% Change 0.24 %
52 Week High 4,500.00
52 Week Low 2,635.00
Volume 1,347
Shares Issued 5.21m
Market Cap £216.65m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.25% below the market average98.25% below the market average98.25% below the market average98.25% below the market average98.25% below the market average
89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average
Price Trend
82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average
Income
76.09% below the market average76.09% below the market average76.09% below the market average76.09% below the market average76.09% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Growth
34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 09-Apr-20 31-Oct-19
Paid 28-Apr-20 15-Nov-19
Amount 36.00p 43.00p

Trades for 10-Jul-2020

Time Volume / Share Price
17:12 237 @ 4,108.97p
16:01 100 @ 4,130.00p
15:50 237 @ 4,125.00p
15:47 60 @ 4,130.00p
15:42 1 @ 4,100.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner
CFO Bruce Hiscock

Top of Page